Cargando…

Cancer Imprints an Increased PARP-1 and p53-Dependent Resistance to Oxidative Stress on Lymphocytes of Patients That Later Develop Alzheimer's Disease

We have proposed that a common biological mechanism deregulated in opposite directions might explain the inverse epidemiological association observed between Alzheimer's disease (AD) and cancer. Accordingly, we showed that lymphocytes from AD patients have an increased susceptibility, whereas t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salech, Felipe, Ponce, Daniela P., SanMartín, Carol D., Rogers, Nicole K., Henríquez, Mauricio, Behrens, Maria I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809443/ https://www.ncbi.nlm.nih.gov/pubmed/29472838 http://dx.doi.org/10.3389/fnins.2018.00058

Ejemplares similares

PARP-1 and p53 Regulate the Increased Susceptibility to Oxidative Death of Lymphocytes from MCI and AD Patients
por: Salech, Felipe, et al.
Publicado: (2017)

Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer’s Disease
por: Salech, Felipe, et al.
Publicado: (2020)

Senescence Markers in Peripheral Blood Mononuclear Cells in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
por: Salech, Felipe, et al.
Publicado: (2022)

Cancer History Avoids the Increase of Senescence Markers in Peripheral Cells of Amnestic Mild Cognitive Impaired Patients
por: SanMartín, Carol D., et al.
Publicado: (2023)

PARP-1 Expression Influences Cancer Stem Cell Phenotype in Colorectal Cancer Depending on p53
por: Puentes-Pardo, Jose D., et al.
Publicado: (2023)

The autophagy protein Def8 is altered in Alzheimer's disease and Aβ42-expressing Drosophila brains
por: Oyarce-Pezoa, Sebastián, et al.
Publicado: (2023)

Software-guided (PREVEDEL) cognitive stimulation to prevent delirium in hospitalised older adults: study protocol
por: Garrido, Maricel, et al.
Publicado: (2023)

PARP1-Driven Apoptosis in Chronic Lymphocytic Leukemia
por: Diamantopoulos, Panagiotis T., et al.
Publicado: (2014)

Position effect variegation and imprinting of transgenes in lymphocytes
por: Williams, Adam, et al.
Publicado: (2008)

Frizzled-1 receptor regulates adult hippocampal neurogenesis
por: Mardones, Muriel D., et al.
Publicado: (2016)

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer’s Disease
por: Espinoza, Sandra, et al.
Publicado: (2022)

PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia
por: Herriott, Ashleigh, et al.
Publicado: (2015)

Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
por: Knittel, Gero, et al.
Publicado: (2017)

Neuroprotective Effects of PARP Inhibitors in Drosophila Models of Alzheimer’s Disease
por: Maggiore, Anna, et al.
Publicado: (2022)

Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease
por: Yu, Yizhou, et al.
Publicado: (2021)

Influenza imprinting in childhood and the influence on vaccine response later in life
por: Kelvin, Alyson A, et al.
Publicado: (2019)

MUTYH, an adenine DNA glycosylase, mediates p53 tumor suppression via PARP-dependent cell death
por: Oka, S, et al.
Publicado: (2014)

MUTYH, an adenine DNA glycosylase, mediates p53 tumor suppression via PARP-dependent cell death
por: Oka, S, et al.
Publicado: (2015)

Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth
por: Zhang, Yizheng, et al.
Publicado: (2022)

Lymphocytic esophagitis: Still an enigma a decade later
por: Rouphael, Carol, et al.
Publicado: (2017)

Correction: Parp mutations protect from mitochondrial toxicity in Alzheimer’s disease
por: Yu, Yizhou, et al.
Publicado: (2021)

Possible Imprinting and Microchimerism in Chronic Lymphocytic Leukemia and Related Lymphoproliferative Disorders
por: Jønsson, Viggo, et al.
Publicado: (2008)

Poly(ADP-RIBOSE) polymerase-1 (Parp-1) antagonizes topoisomerase I-dependent recombination stimulation by P53
por: Baumann, Cindy, et al.
Publicado: (2006)

BRCA1 and TP53 codeficiency causes a PARP inhibitor–sensitive erythroproliferative neoplasm
por: Lopez-Perez, Gerardo, et al.
Publicado: (2022)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
por: Yélamos, José, et al.
Publicado: (2020)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
por: van Beek, Lotte, et al.
Publicado: (2021)

The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity
por: Becker, Jordan R., et al.
Publicado: (2018)

Thyroid hormone determines the start of the sensitive period of imprinting and primes later learning
por: Yamaguchi, Shinji, et al.
Publicado: (2012)

Imprinting methylation predicts hippocampal volumes and hyperintensities and the change with age in later life
por: Lorgen-Ritchie, Marlene, et al.
Publicado: (2021)

PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage
por: Rulten, Stuart L., et al.
Publicado: (2014)

Identification of a novel imprinting mechanism at the X-linked imprinted locus, X-linked Lymphocyte Regulated 3/4 (Xlr3/4)
por: Qureshi, Sohaib M, et al.
Publicado: (2013)

BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance
por: Nacson, Joseph, et al.
Publicado: (2018)

Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination
por: Robert, Isabelle, et al.
Publicado: (2009)

Implication of the Strand-Specific Imprinting and Segregation Model: Integrating in utero Hormone Exposure, Stem Cell and Lateral Asymmetry Hypotheses in Breast Cancer Aetiology
por: Harbinder, Singh, et al.
Publicado: (2013)

Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53
por: Williamson, Chris T, et al.
Publicado: (2012)

53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells
por: Hong, Ruoxi, et al.
Publicado: (2016)

Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease
por: Pérez, María J., et al.
Publicado: (2017)

PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
por: Lin, Xiaohui, et al.
Publicado: (2022)

Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity
por: Rodda, Lauren B., et al.
Publicado: (2022)

The effect of rapamycin and its analogues on age-related musculoskeletal diseases: a systematic review
por: Lin, Hong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ijqevojm4jkaqi7ht08rjch5io